ArticlePharmaceutics2020

Recombinant Protein-Based Nanoparticles: Elucidating their Inflammatory Effects In Vivo and their Potential as a New Therapeutic Format.

Laia Gifre-Renom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.